Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
1997 2
1998 3
2000 4
2001 1
2003 2
2004 5
2005 7
2006 3
2007 1
2009 4
2010 10
2011 12
2012 7
2013 11
2014 6
2015 17
2016 8
2017 4
2018 7
2019 6
2020 6
2021 7
2022 4
2023 3
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
Enucleation.
Moshfeghi DM, Moshfeghi AA, Finger PT. Moshfeghi DM, et al. Among authors: moshfeghi aa. Surv Ophthalmol. 2000 Jan-Feb;44(4):277-301. doi: 10.1016/s0039-6257(99)00112-5. Surv Ophthalmol. 2000. PMID: 10667436 Free article. Review.
Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
Haller JA, Bandello F, Belfort R Jr, Blumenkranz MS, Gillies M, Heier J, Loewenstein A, Yoon YH, Jacques ML, Jiao J, Li XY, Whitcup SM; OZURDEX GENEVA Study Group. Haller JA, et al. Ophthalmology. 2010 Jun;117(6):1134-1146.e3. doi: 10.1016/j.ophtha.2010.03.032. Epub 2010 Apr 24. Ophthalmology. 2010. PMID: 20417567 Clinical Trial.
Intraocular Pressure-Related Events After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Due to Central Retinal Vein Occlusion or Hemiretinal Vein Occlusion: SCORE2 Report 16 on a Secondary Analysis of a Randomized Clinical Trial.
Aref AA, Scott IU, VanVeldhuisen PC, King J, Ip MS, Blodi BA, Oden NL; Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2) Investigator Group. Aref AA, et al. JAMA Ophthalmol. 2021 Dec 1;139(12):1285-1291. doi: 10.1001/jamaophthalmol.2021.4395. JAMA Ophthalmol. 2021. PMID: 34709363 Free PMC article. Clinical Trial.
Ocular Tolerance of Contemporary Electronic Display Devices.
Clark AJ, Yang P, Khaderi KR, Moshfeghi AA. Clark AJ, et al. Among authors: moshfeghi aa. Ophthalmic Surg Lasers Imaging Retina. 2018 May 1;49(5):346-354. doi: 10.3928/23258160-20180501-08. Ophthalmic Surg Lasers Imaging Retina. 2018. PMID: 29772045 Review.
Micro- and nanoparticulates.
Moshfeghi AA, Peyman GA. Moshfeghi AA, et al. Adv Drug Deliv Rev. 2005 Dec 13;57(14):2047-52. doi: 10.1016/j.addr.2005.09.006. Epub 2005 Nov 17. Adv Drug Deliv Rev. 2005. PMID: 16298454 Review.
Ocriplasmin: a medical or surgical therapy?
Duker JS, Moshfeghi AA. Duker JS, et al. Among authors: moshfeghi aa. Retina. 2013 Nov-Dec;33(10):2001-2. doi: 10.1097/IAE.0000000000000016. Retina. 2013. PMID: 24113274 No abstract available.
128 results